Bayesian Capital Management’s Proofpoint, Inc. PFPT Stock Holding History

Bayesian Capital Management’s Portfolio PFPT Stock Details PFPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,600	Closed	-$278K	–	606
2021 Q2	$278K	Buy	+1,600	New	+$260K	0.07%	298
2017 Q3	–	Sell	-6,469	Closed	-$562K	–	698
2017 Q2	$562K	Buy	+6,469	New	+$532K	0.21%	165
2017 Q1	–	Sell	-11,369	Closed	-$803K	–	764
2016 Q4	$803K	Buy	11,369 +5,800	+104%	+$436K	0.2%	185
2016 Q3	$417K	Buy	5,569 +2,000	+56%	+$148K	0.27%	129
2016 Q2	$225K	Buy	+3,569	New	+$204K	0.13%	301
2016 Q1	–	Sell	-3,849	Closed	-$250K	–	463
2015 Q4	$250K	Buy	+3,849	New	+$258K	0.36%	131

Other funds holding PFPT

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

Bayesian Capital Management's PFPT Position: Q3 2021 in Review

Bayesian Capital Management sold out of Proofpoint, Inc. (PFPT) in Q3 2021, closing a stake of 1,600 shares — an estimated $278K sold.

Bayesian Capital Management first reported a position in PFPT in Q4 2015 and held it in 6 quarters. The position peaked at $803K in Q4 2016. 2 funds tracked by Wall St. Rank hold PFPT as of Q3 2021.

Bayesian Capital Management reported no remaining Proofpoint, Inc. position as of Q3 2021 after selling out during the quarter.
Bayesian Capital Management sold 1,600 Proofpoint, Inc. shares in Q3 2021, an estimated $278K.
Bayesian Capital Management first reported a position in Proofpoint, Inc. in Q4 2015 and held it in 6 quarters.
Bayesian Capital Management's Proofpoint, Inc. position peaked at $803K in Q4 2016.
2 funds tracked by Wall St. Rank held Proofpoint, Inc. as of Q3 2021.

Based on Bayesian Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.